Literature DB >> 18666807

Estimates of relative risks for cancers in a population after prolonged low-dose-rate radiation exposure: a follow-up assessment from 1983 to 2005.

Su-Lun Hwang1, Jing-Shiang Hwang, Yi-Ta Yang, Wanhua A Hsieh, Tien-Chun Chang, How-Ran Guo, Mong-Hsun Tsai, Jih-Luh Tang, I-Feng Lin, Wushou Peter Chang.   

Abstract

Radiation effects on cancer risks in a cohort of Taiwanese residents who received protracted low-dose-rate gamma-radiation exposures from (60)Co-contaminated reinforcing steel used to build their apartments were studied, and risks were compared to those in other radiation-exposed cohorts. Analyses were based on a more extended follow-up of the cohort population in which 117 cancer cases diagnosed between 1983 and 2005 among 6,242 people with an average excess cumulative exposure estimate of about 48 mGy. Cases were identified from Taiwan's National Cancer Registry. Radiation effects on cancer risk were estimated using proportional hazards models and were summarized in terms of the hazard ratio associated with a 100-mGy increase in dose (HR(100mGy)). A significant radiation risk was observed for leukemia excluding chronic lymphocytic leukemia (HR(100mGy) 1.19, 90% CI 1.01-1.31). Breast cancer exhibited a marginally significant dose response (HR(100mGy) 1.12, 90% CI 0.99-1.21). The results further strengthen the association between protracted low-dose radiation and cancer risks, especially for breast cancers and leukemia, in this unique cohort population.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18666807     DOI: 10.1667/RR0732.1

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  17 in total

1.  The healthy worker effect and nuclear industry workers.

Authors:  Krzysztof W Fornalski; Ludwik Dobrzyński
Journal:  Dose Response       Date:  2010-01-06       Impact factor: 2.658

2.  Perspective on the use of LNT for radiation protection and risk assessment by the U.S. Environmental Protection Agency.

Authors:  Jerome S Puskin
Journal:  Dose Response       Date:  2009-08-21       Impact factor: 2.658

3.  Low dose radiation adaptive protection to control neurodegenerative diseases.

Authors:  Mohan Doss
Journal:  Dose Response       Date:  2013-09-12       Impact factor: 2.658

4.  Global gene expression responses to low- or high-dose radiation in a human three-dimensional tissue model.

Authors:  Alexandre Mezentsev; Sally A Amundson
Journal:  Radiat Res       Date:  2011-04-12       Impact factor: 2.841

5.  Linear No-Threshold Model VS. Radiation Hormesis.

Authors:  Mohan Doss
Journal:  Dose Response       Date:  2013-05-24       Impact factor: 2.658

Review 6.  Strengths and Weaknesses of Dosimetry Used in Studies of Low-Dose Radiation Exposure and Cancer.

Authors:  Robert D Daniels; Gerald M Kendall; Isabelle Thierry-Chef; Martha S Linet; Harry M Cullings
Journal:  J Natl Cancer Inst Monogr       Date:  2020-07-01

Review 7.  A meta-analysis of leukaemia risk from protracted exposure to low-dose gamma radiation.

Authors:  R D Daniels; M K Schubauer-Berigan
Journal:  Occup Environ Med       Date:  2010-10-08       Impact factor: 4.402

Review 8.  Is the Linear No-Threshold Dose-Response Paradigm Still Necessary for the Assessment of Health Effects of Low Dose Radiation?

Authors:  Ki Moon Seong; Songwon Seo; Dalnim Lee; Min-Jeong Kim; Seung-Sook Lee; Sunhoo Park; Young Woo Jin
Journal:  J Korean Med Sci       Date:  2016-01-28       Impact factor: 2.153

9.  Resistance of Feather-Associated Bacteria to Intermediate Levels of Ionizing Radiation near Chernobyl.

Authors:  Mario Xavier Ruiz-González; Gábor Árpád Czirják; Pierre Genevaux; Anders Pape Møller; Timothy Alexander Mousseau; Philipp Heeb
Journal:  Sci Rep       Date:  2016-03-15       Impact factor: 4.379

10.  30 years follow-up and increased risks of breast cancer and leukaemia after long-term low-dose-rate radiation exposure.

Authors:  Wan-Hua Hsieh; I-Feng Lin; Jung-Chun Ho; Peter Wushou Chang
Journal:  Br J Cancer       Date:  2017-10-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.